Home > Insider Trading > Filing (0001181431-13-033331)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1576141	L.p. I Fund Venture Astellas	2882 Sand Hill Road Suite 121 Menlo Park CA 94025		No	No	Yes	No
1577630	Astellas Venture Management Llc	2882 Sand Hill Road Suite 121 Menlo Park CA 94025		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-05	634,920	$0.00	634,920	No	4	C	Direct
Common Stock	Acquisiton	2013-06-05	15,333	$15.00	650,253	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2013-06-05	1,904,762	$0.00	634,920	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into 1/3rd of a share of Common Stock without payment of further consideration. The shares have no expiration date.
These shares are owned directly by Astellas Venture Fund I LP (the "Fund") and indirectly held by Astellas Venture Management LLC (the "LLC"), the sole general partner of the Fund. The LLC disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.